Type 1 Diabetes Clinical Trial
— Santal-DT1Official title:
Study of the Characteristics of Orthorexia Nervosa in the Population Living With Type 1 Diabetes
NCT number | NCT05546281 |
Other study ID # | 2023-3914, 22258 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | October 1, 2022 |
Est. completion date | May 2024 |
In the general population, the excessive and constant desire to control one's diet and body has become increasingly problematic. Indeed, the demand for control over one's diet and body is now an unspoken social prescription that can lead in some cases to eating disorders. In patients with type 1 diabetes (T1D), these concerns are even more central, as they are accentuated by the very nature of the treatment of the disease (dietary modification, insulin compensation according to food intake, etc.). Studies on adolescents with T1D show that the prevalence of eating disorders would be present in at least 1 in 5 patients. Among these disorders, orthorexia is of particular interest. Indeed, orthorexia was defined in 1997 by Steven Bratman as a rigid eating behavior based on the avoidance of foods considered qualitatively unhealthy. More precisely, orthorexia is characterized by a constant preoccupation with one's diet and persistent nutritional (or health) beliefs that take precedence over food pleasure. It has been estimated that the prevalence of orthorexia in patients living with T1D may be as high as 80%. We are currently conducting a study on the mechanisms of orthorexia in the general population of Quebec (the results of phase 1 of this study are being analyzed). We now wish to conduct the same study in a population with T1D, which has a higher prevalence of people with orthorexia nervosa. The main objective of this study is to investigate the characteristics of orthorexia nervosa (obsessions and fixations on healthy eating) in the Quebec population with T1D from the BETTER Registry.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | May 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Person living with type 1 diabetes - French speaking - Between 18 and 35 years old Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
Canada | Centre d'expertise Poids, Image et Alimentation (CEPIA) | Québec | |
Canada | IUCPQ | Québec |
Lead Sponsor | Collaborator |
---|---|
Laval University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Forced food categorization task according to the categories "healthy / unhealthy" | Instruction to the participant: "Classify the food that appears on your screen as quickly as possible, either as "healthy" (key E) or "unhealthy" (key I).
Each response and the associated reaction time will be recorded. Stimuli must be classified by the participant as quickly as possible, if the stimulus is not classified before 3 sec the participant moves to the next observation and the stimulus is recorded as NC (not classified). |
Baseline | |
Secondary | Stroop Task | Task aimed at evaluating the participant's inhibition and selective attention abilities. | Baseline | |
Secondary | Trail Making Test (TMT) | Task to assess the participant's cognitive flexibility. | Baseline | |
Secondary | Age | In years. | Baseline | |
Secondary | Gender | Baseline | ||
Secondary | Weight | In kg. | Baseline | |
Secondary | Height | In meters. | Baseline | |
Secondary | Diabetes Information : Age of appearance and duration | In years. | Baseline | |
Secondary | Diabetes Information : How insulin is administered | Pumps or injections. | Baseline | |
Secondary | Diabetes Information : Total dose of insulin | For one day. | Baseline | |
Secondary | Diabetes Information : Duration of diabetes self-monitoring | Number of years or months of its use, either self-monitoring with capillary glucose tests or CGMS, if so. | Baseline | |
Secondary | Diabetes Information : Severe hypoglycemic episodes | Number of severe hypoglycemic episodes over the last year. | Baseline | |
Secondary | Diabetes Information : Diabetes complications | Number and type of diabetes complications. | Baseline | |
Secondary | Eating Habit Questionnaire (EHQ) | Questionnaires for the detection of orthorexic traits.
Individual subscale and total scale scores are summed, with higher scores indicating increased orthorexia nervosa tendencies. The minimum score is 0 and the maximum score is 48. |
Baseline | |
Secondary | Ortho-15 Questionnaire | Questionnaires for the detection of orthorexic traits.
The total score is obtained by adding the scores on each item. A low score on this tool indicates orthorexic tendencies. The minimum score is 16 and the maximum is 39. |
Baseline | |
Secondary | Eating Disorder Examination Questionnaire (EDE-Q) | Questionnaire for the detection of eating disorders.
The EDE-Q generates two types of data: frequency data on key behavioural features of eating disorders in terms of number of episodes of the behaviour, and subscale scores reflecting the severity of characteristics of eating disorders.Higher scores on the global scale and subscales denote more problematic eating behaviours and attitudes. The minimum score is 0 and the maximum score is 6 for the subscales and the overall scale. |
Baseline | |
Secondary | Type 1 Diabetes Distress Scale (T1-DDS) | Questionnaire for the assessment of type 1 diabetes distress.
The scale yields an overall distress score based on average responses along the 1-6 scale for all 28 items (range = 1-6). The scale also yields a score for each of 7 subscales based on the average response on all of the items in that subscale (range = 1-6). The higher the score, the higher the distress. |
Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Completed |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
Completed |
NCT02855307 -
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT02897557 -
Insulet Artificial Pancreas Early Feasibility Study
|
N/A |